Nie Zhenyu, Chen Mei, Gao Yuanhui, Huang Denggao, Cao Hui, Peng Yanling, Guo Na, Wang Fei, Zhang Shufang
Central Laboratory, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, China.
Department of Urology, Hainan General Hospital, Affiliated Hainan Hospital of Hainan Medical University, Haikou, China.
Front Pharmacol. 2022 May 20;13:879317. doi: 10.3389/fphar.2022.879317. eCollection 2022.
Ferroptosis is a novel type of regulated cell death, whose unique metabolic characteristics are commonly used to evaluate the conditions of various diseases especially in tumors. Accumulating evidence supports that ferroptosis can regulate tumor development, metastasis, and therapeutic responses. Considering to the important role of chemotherapy in tumor treatment, drug resistance has become the most serious challenge. Revealing the molecular mechanism of ferroptosis is expected to solve tumor drug resistance and find new therapies to treat cancers. In this review, we discuss the relationship between ferroptosis and tumor drug resistance, summarize the abnormal ferroptosis in tissues of different cancer types and current research progress and challenges in overcoming treatment resistance, and explore the concept of targeting ferroptosis to improve tumor treatment outcomes.
铁死亡是一种新型的程序性细胞死亡,其独特的代谢特征通常用于评估各种疾病的状况,尤其是肿瘤。越来越多的证据支持铁死亡可以调节肿瘤的发展、转移和治疗反应。考虑到化疗在肿瘤治疗中的重要作用,耐药性已成为最严峻的挑战。揭示铁死亡的分子机制有望解决肿瘤耐药性问题,并找到治疗癌症的新疗法。在这篇综述中,我们讨论了铁死亡与肿瘤耐药性之间的关系,总结了不同癌症类型组织中的铁死亡异常以及当前克服治疗耐药性的研究进展和挑战,并探讨了靶向铁死亡以改善肿瘤治疗效果的概念。